Additional less-studied proposed factors include nuclear transcription factors that regulate cellular defense against oxidative damage, such as SNRX1, NRF2, and DJ2, which may have prognostic implications in IDH-mutant GBM cohorts in addition to IDH-mutant lower-grade astrocytomas [55]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).